These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30182875)

  • 21. Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies.
    Ralph LJ; McCoy SI; Shiu K; Padian NS
    Lancet Infect Dis; 2015 Feb; 15(2):181-9. PubMed ID: 25578825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.
    Grabowski MK; Gray RH; Makumbi F; Kagaayi J; Redd AD; Kigozi G; Reynolds SJ; Nalugoda F; Lutalo T; Wawer MJ; Serwadda D; Quinn TC; Tobian AAR
    Lancet Glob Health; 2015 Aug; 3(8):e478-e486. PubMed ID: 26094162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical experience with injectable progestogen- only contraceptives at University of Ilorin teaching hospital: a five year review.
    Balogun OR; Raji HO
    Niger Postgrad Med J; 2009 Dec; 16(4):260-3. PubMed ID: 20037621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-Evaluating the Possible Increased Risk of HIV Acquisition With Progestin-Only Injectables Versus Maternal Mortality and Life Expectancy in Africa: A Decision Analysis.
    Rodriguez MI; Gaffield ME; Han L; Caughey AB
    Glob Health Sci Pract; 2017 Dec; 5(4):581-591. PubMed ID: 29284696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New contraceptive eligibility checklists for provision of combined oral contraceptives and depot-medroxyprogesterone acetate in community-based programmes.
    Stang A; Schwingl P; Rivera R
    Bull World Health Organ; 2000; 78(8):1015-23. PubMed ID: 10994285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicians' perceptions and provision of hormonal contraceptives for HIV-positive and at-risk women in Southern Africa: an original research article.
    Blanchard K; Chipato T; Ramjee G; Nhemachena T; Harper CC;
    Contraception; 2014 Oct; 90(4):391-8. PubMed ID: 24924260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormonal contraceptive continuation and switching in South Africa: implications for evaluating the association of injectable hormonal contraceptive use and HIV.
    Smit JA; Beksinska ME
    J Acquir Immune Defic Syndr; 2013 Mar; 62(3):363-5. PubMed ID: 23187946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helping women choose appropriate hormonal contraception: update on risks, benefits, and indications.
    Spencer AL; Bonnema R; McNamara MC
    Am J Med; 2009 Jun; 122(6):497-506. PubMed ID: 19486709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women.
    Baeten JM; Benki S; Chohan V; Lavreys L; McClelland RS; Mandaliya K; Ndinya-Achola JO; Jaoko W; Overbaugh J
    AIDS; 2007 Aug; 21(13):1771-7. PubMed ID: 17690576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Contraceptives, HIV, and other sexually transmitted diseases].
    Vandale-Toney S; Conde-González CJ
    Ginecol Obstet Mex; 1995 Jan; 63():40-5. PubMed ID: 7896158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of the World Health Organization's Medical Eligibility Criteria for Contraceptive Use Guidance in sub-Saharan African Countries: A Cross-Sectional Study.
    Chen MJ; Gaffield ME; Kiarie J
    Glob Health Sci Pract; 2016 Sep; 4(3):506-10. PubMed ID: 27688720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New recommendations from the World Health Organization (WHO) for the use of contraceptive methods].
    Cravioto MD
    Gac Med Mex; 2016; 152(5):601-603. PubMed ID: 27792693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
    Kaunitz AM
    J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches.
    Polis CB; Westreich D; Balkus JE; Heffron R;
    AIDS; 2013 Oct; 27 Suppl 1(0 1):S35-43. PubMed ID: 24088682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
    Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK
    Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Missed hormonal contraceptives: new recommendations.
    Guilbert E; Black A; Dunn S; Senikas V; ;
    J Obstet Gynaecol Can; 2008 Nov; 30(11):1050-1062. PubMed ID: 19126288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Need for Policy Change Regarding Progestin-Only Injectable Contraceptives.
    Gollub EL; Jones HE; Ralph LJ; van de Wijgert JHHM; Padian N; Stein Z
    J Womens Health (Larchmt); 2019 Sep; 28(9):1180-1184. PubMed ID: 30576259
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.